(b)(6).On (b)(6) 2021 an amplatzer valvular plug iii was selected for implant in the patient with the following comorbidities: atrial fibrillation, gastrointestinal bleeding, hyperlipidemia, hypertension, duodenal angiodysplasia and previous mitral and aortic valve replacements(on-x valves).The patient's access site was through the femoral artery using a 7f amplatzer torqvue 2 delivery sheath.The plug was successfully implanted in the patient and remains implanted.On (b)(6) 2021, the patient experienced vascular access complications prior to discharge.A hematoma appeared on the patient's right thigh.A femoral artery fistula was observed some days after the procedure.The patient was treated with a compressive bandage and the event was resolved without sequelae on (b)(6) 2021.Additionally, the patients hemolytic anemia worsened and the patient was treated with transfusion of 2 concentrate.The patient is currently stable.
|
An event of hematoma, femoral artery fistula, and hemolytic anemia was reported.A more comprehensive assessment could not be performed as the device was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
|